These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22700816)

  • 1. Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
    Stewart N; Simpson S; van der Mei I; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; Eyles D; Ko P; Taylor BV
    Neurology; 2012 Jul; 79(3):254-60. PubMed ID: 22700816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating effects of WT1 on interferon-β-vitamin D association in MS.
    Lin R; Taylor BV; Charlesworth J; van der Mei I; Blizzard L; Stewart N; Ponsonby AL; Dwyer T; Pittas F; Simpson S
    Acta Neurol Scand; 2015 Apr; 131(4):231-9. PubMed ID: 25312909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
    JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis.
    Simpson S; Taylor B; Blizzard L; Ponsonby AL; Pittas F; Tremlett H; Dwyer T; Gies P; van der Mei I
    Ann Neurol; 2010 Aug; 68(2):193-203. PubMed ID: 20695012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
    Tremlett H; van der Mei IA; Pittas F; Blizzard L; Paley G; Mesaros D; Woodbaker R; Nunez M; Dwyer T; Taylor BV; Ponsonby AL
    Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of reported sun exposure, and not vitamin D status, are associated with less depressive symptoms and fatigue in multiple sclerosis.
    Knippenberg S; Damoiseaux J; Bol Y; Hupperts R; Taylor BV; Ponsonby AL; Dwyer T; Simpson S; van der Mei IA
    Acta Neurol Scand; 2014 Feb; 129(2):123-31. PubMed ID: 23763464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
    Soilu-Hänninen M; Aivo J; Lindström BM; Elovaara I; Sumelahti ML; Färkkilä M; Tienari P; Atula S; Sarasoja T; Herrala L; Keskinarkaus I; Kruger J; Kallio T; Rocca MA; Filippi M
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):565-71. PubMed ID: 22362918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
    Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
    Løken-Amsrud KI; Holmøy T; Bakke SJ; Beiske AG; Bjerve KS; Bjørnarå BT; Hovdal H; Lilleås F; Midgard R; Pedersen T; Benth JS; Sandvik L; Torkildsen O; Wergeland S; Myhr KM
    Neurology; 2012 Jul; 79(3):267-73. PubMed ID: 22700809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 and interferon-β-vitamin D association in MS: a longitudinal study.
    Holmøy T; Esbensen QY; Torkildsen Ø; Wergeland S; Bjerve KS; Beiske AG; Midgard R; Šaltytė-Benth J; Hovdal H; Myhr KM
    Acta Neurol Scand; 2016 Apr; 133(4):309-12. PubMed ID: 26037530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
    Slavov GS; Manova MG; Trenova AG; Kostadinova II; Pavlov PI; Mateva NG; Zahariev ZI
    Folia Med (Plovdiv); 2015; 57(3-4):200-6. PubMed ID: 27180346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal variations of 25-OH vitamin D serum levels are associated with clinical disease activity in multiple sclerosis patients.
    Hartl C; Obermeier V; Gerdes LA; Brügel M; von Kries R; Kümpfel T
    J Neurol Sci; 2017 Apr; 375():160-164. PubMed ID: 28320120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sun exposure and vitamin D are independent risk factors for CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery PC; Pender MP; Taylor BV; Kilpatrick TJ; Dwyer T; Coulthard A; Chapman C; van der Mei I; Williams D; McMichael AJ
    Neurology; 2011 Feb; 76(6):540-8. PubMed ID: 21300969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
    Behrens JR; Rasche L; Gieß RM; Pfuhl C; Wakonig K; Freitag E; Deuschle K; Bellmann-Strobl J; Paul F; Ruprecht K; Dörr J
    Eur J Neurol; 2016 Jan; 23(1):62-7. PubMed ID: 26220765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
    van der Mei IA; Ponsonby AL; Dwyer T; Blizzard L; Taylor BV; Kilpatrick T; Butzkueven H; McMichael AJ
    J Neurol; 2007 May; 254(5):581-90. PubMed ID: 17426912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of vitamin D and multiple sclerosis in India.
    Pandit L; Ramagopalan SV; Malli C; D'Cunha A; Kunder R; Shetty R
    Mult Scler; 2013 Oct; 19(12):1592-6. PubMed ID: 23519972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Ostkamp P; Salmen A; Pignolet B; Görlich D; Andlauer TFM; Schulte-Mecklenbeck A; Gonzalez-Escamilla G; Bucciarelli F; Gennero I; Breuer J; Antony G; Schneider-Hohendorf T; Mykicki N; Bayas A; Then Bergh F; Bittner S; Hartung HP; Friese MA; Linker RA; Luessi F; Lehmann-Horn K; Mühlau M; Paul F; Stangel M; Tackenberg B; Tumani H; Warnke C; Weber F; Wildemann B; Zettl UK; Ziemann U; Müller-Myhsok B; Kümpfel T; Klotz L; Meuth SG; Zipp F; Hemmer B; Hohlfeld R; Brassat D; Gold R; Gross CC; Lukas C; Groppa S; Loser K; Wiendl H; Schwab N;
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33376202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sunlight exposure in determining the vitamin D status of the U.K. white adult population.
    Webb AR; Kift R; Durkin MT; O'Brien SJ; Vail A; Berry JL; Rhodes LE
    Br J Dermatol; 2010 Nov; 163(5):1050-5. PubMed ID: 20716215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D as an early predictor of multiple sclerosis activity and progression.
    Ascherio A; Munger KL; White R; Köchert K; Simon KC; Polman CH; Freedman MS; Hartung HP; Miller DH; Montalbán X; Edan G; Barkhof F; Pleimes D; Radü EW; Sandbrink R; Kappos L; Pohl C
    JAMA Neurol; 2014 Mar; 71(3):306-14. PubMed ID: 24445558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.
    Keyzer CA; Lambers-Heerspink HJ; Joosten MM; Deetman PE; Gansevoort RT; Navis G; Kema IP; de Zeeuw D; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2119-27. PubMed ID: 26450935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.